EMA Authorised: Viread (tenofovir disoproxil fumarate) — Gilead Sciences Ireland UC

View source ↗

Summary

The European Medicines Agency authorised Viread (tenofovir disoproxil fumarate) for chronic hepatitis B and HIV infections; the marketing authorization holder i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Status: Authorised. Therapeutic area: Hepatitis B, Chronic;HIV Infections. MAH: Gilead Sciences Ireland UC. Decision date: 16/02/2024